Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD

NCT02341326 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT02341326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
October 29, 2024
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, lung disorder, smoking